The importance of interleukin 1beta in Helicobacter pylori associated disease.
El-Omar
E M
EM
Department of Medicine and Therapeutics Aberdeen University, Polwarth Building, Foresterhill Aberdeen AB25 2ZD, UK. e.el-omar@abdn.ac.uk
D000818:Animals; D005744:Gastric Acid / Q000378:metabolism; D005753:Gastric Mucosa / Q000502:physiology; D005756:Gastritis / Q000276:immunology*; D020022:Genetic Predisposition to Disease; D016481:Helicobacter Infections / Q000276:immunology*; D016480:Helicobacter pylori; D006801:Humans; D018836:Inflammation Mediators / Q000276:immunology; D007375:Interleukin-1 / Q000235:genetics / Q000494:pharmacology / Q000502:physiology*; D011110:Polymorphism, Genetic; D011817:Rabbits; D051381:Rats; D017472:Receptors, Interleukin-1 / Q000502:physiology; D013274:Stomach Neoplasms / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D018836:Inflammation Mediators; D007375:Interleukin-1; D017472:Receptors, Interleukin-1; D014409:Tumor Necrosis Factor-alpha